Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regenacell Therapy is a private U.S. regenerative medicine and orthobiologics company focused on medical devices and biologic procedure systems for musculoskeletal, spine, sports medicine, extremity, oral-maxillofacial, and aesthetic applications. The company markets products including the CellFUSE bone graft line and previously launched the Lipo-Pro adipose harvesting and fat grafting system with manufacturing partner Ranfac. Its positioning is centered on supplying clinicians with point-of-care orthobiologic devices, training, and post-sales support rather than developing traditional drug therapeutics. Available evidence indicates the business is commercial-stage, small, and privately held, with operations based in Castle Rock, Colorado.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenacell Therapy.